Amalgamated Bank Arbutus Biopharma Corp Transaction History
Amalgamated Bank
- $12.2 Billion
- Q4 2024
A detailed history of Amalgamated Bank transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Amalgamated Bank holds 4,448 shares of ABUS stock, worth $14,856. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,448
Previous 4,448
-0.0%
Holding current value
$14,856
Previous $17,000
11.76%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ABUS
# of Institutions
165Shares Held
102MCall Options Held
649KPut Options Held
666K-
Morgan Stanley New York, NY22.6MShares$75.4 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.2MShares$44.2 Million22.74% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$38.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.98MShares$30 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.74MShares$29.2 Million4.68% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $501M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...